These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2579201)

  • 1. Drug potencies on partially purified brain D2 dopamine receptors.
    Madras BK; Seeman P
    J Neurochem; 1985 Mar; 44(3):856-61. PubMed ID: 2579201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
    Clagett-Dame M; Schoenleber R; Chung C; McKelvy JF
    Biochim Biophys Acta; 1989 Nov; 986(2):271-80. PubMed ID: 2531613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of the D-2 dopamine receptor from bovine striatum.
    Elazar Z; Kanety H; David C; Fuchs S
    Biochem Biophys Res Commun; 1988 Oct; 156(1):602-9. PubMed ID: 2972288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilization of neuroleptic/dopamine receptors of human brain striatum.
    Davis A; Madras B; Seeman P
    Eur J Pharmacol; 1981 Mar; 70(3):321-9. PubMed ID: 6112153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of specificity and stereoselectivity of rat brain dopamine receptors.
    Miller JC; Friedhoff AJ
    Int J Dev Neurosci; 1986; 4(1):21-6. PubMed ID: 2458672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubilization and characterization of striatal dopamine receptors.
    Lew JY; Goldstein M
    J Neurochem; 1984 May; 42(5):1298-305. PubMed ID: 6707634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization of D2 dopamine receptor coupled to guanine nucleotide regulatory protein from bovine striatum.
    Kuno T; Saijoh K; Tanaka C
    J Neurochem; 1983 Sep; 41(3):841-7. PubMed ID: 6308173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations.
    Kazmi SM; Ramwani J; Srivastava LK; Rajakumar G; Ross GM; Cullen M; Mishra RK
    J Neurochem; 1986 Nov; 47(5):1493-502. PubMed ID: 3760872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR; Watanabe M; Seeman P
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimisation of conditions for solubilisation of the bovine dopamine D2 receptor.
    Hooper RJ
    J Neurochem; 1986 Oct; 47(4):1080-5. PubMed ID: 2943871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoaffinity labelling of dopamine D2 receptors by [3H]azidomethylspiperone.
    Niznik HB; Grigoriadis DE; Seeman P
    FEBS Lett; 1986 Dec; 209(1):71-6. PubMed ID: 2948835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the use of a novel affinity matrix, sepharose amine-succinyl-amine haloperidol hemisuccinate, ASA-HHS, for purification of canine dopamine (D2) receptor.
    Antonian L; Antonian E; Murphy RB; Schuster DI
    Life Sci; 1986 May; 38(20):1847-58. PubMed ID: 3010025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of soluble dopamine D2-receptors from three species.
    Madras BK; Davis A; Seeman P
    Eur J Pharmacol; 1982 Mar; 78(4):431-8. PubMed ID: 7075677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of affinity-purified dopamine D2 receptor binding activities by specific lipids.
    Srivastava LK; Kazmi SM; Blume AJ; Mishra RK
    Biochim Biophys Acta; 1987 Jun; 900(2):175-82. PubMed ID: 2954584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
    Niznik HB; Guan JH; Neumeyer JL; Seeman P
    Mol Pharmacol; 1985 Feb; 27(2):193-9. PubMed ID: 3969068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2 receptors photolabeled by iodo-azido-clebopride.
    Niznik HB; Dumbrille-Ross A; Guan JH; Neumeyer JL; Seeman P
    Neurosci Lett; 1985 Apr; 55(3):267-72. PubMed ID: 3159976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilization of dopamine D2 receptors with a zwitterionic detergent DCHAPS.
    Soskić V; Petrović J
    Biochem Pharmacol; 1986 Dec; 35(23):4229-36. PubMed ID: 2947577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.